Showing results (1541-1550 of 1,605) with videos related to

Sort By:
Pageof 161
The Lancet. Oncology|April 7, 2020
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trialSarah B Goldberg, Kurt A Schalper, Scott N Gettinger, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
Eclinicalmedicine|July 22, 2022
Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trialDavid Hubacher, Courtney A Schreiber, David K Turok, et al.
Nature Communications|March 10, 2022
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infectionsHattie Chung, Christina Merakou, Matthew M Schaefers, et al.
Cancer Discovery|December 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug DevelopmentJoshua M Donaldson, Marjilla Seddiq, Michael J Fusco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation-Associated Advanced Ovarian CancerSanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, et al.
Advances in Microbial Physiology|November 27, 2021
The Pseudomonas aeruginosa whole genome sequence: A 20th anniversary celebrationFiona S L Brinkman, Geoffrey L Winsor, Rachel E Done, et al.
The Lancet. Oncology|July 26, 2021
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Lijun Zhang, Anup Amatya, et al.
Cancer Discovery|October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerScott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Pageof 161